CMND - CIK 0001892500
The table below shows Clearmind Medicine Inc.'s income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - |
| Gross profit | - | - | - | - | - |
| R&D | $2.06M | $1.38M | $1.54M | $3.08M | $473.65K |
| SG&A | - | $4.36M | $4.76M | $3.17M | $2.22M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Operating income |
| - |
| - |
| - |
| - |
| - |
| Income tax | - | - | - | - | - |
| Net income | - | - | - | - | - |
| EPS (diluted) | - | - | - | - | - |